Baillie Gifford & Co’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-531
Closed -$36.8K 317
2023
Q1
$36.8K Buy
531
+73
+16% +$5.15K ﹤0.01% 300
2022
Q4
$33K Hold
458
﹤0.01% 312
2022
Q3
$33K Sell
458
-30
-6% -$2.18K ﹤0.01% 303
2022
Q2
$38K Buy
488
+25
+5% +$1.9K ﹤0.01% 301
2022
Q1
$34K Buy
463
+36
+8% +$2.42K ﹤0.01% 308
2021
Q4
$27K Sell
427
-47
-10% -$2.76K ﹤0.01% 339
2021
Q3
$28K Sell
474
-88
-16% -$5.79K ﹤0.01% 325
2021
Q2
$38K Sell
562
-45
-7% -$2.93K ﹤0.01% 298
2021
Q1
$38K Buy
607
+24
+4% +$1.49K ﹤0.01% 293
2020
Q4
$36K Buy
+583
New +$35.8K ﹤0.01% 283
2017
Q3
Sell
-177,742
Closed -$9.9M 201
2017
Q2
$9.9M Hold
177,742
0.01% 161
2017
Q1
$9.67M Sell
177,742
-8,639
-5% -$474K 0.01% 155
2016
Q4
$10.9M Buy
186,381
+2,596
+1% +$142K 0.02% 153
2016
Q3
$9.91M Hold
183,785
0.02% 156
2016
Q2
$13.5M Sell
183,785
-61,640
-25% -$4.36M 0.02% 137
2016
Q1
$15.7M Sell
245,425
-8,843
-3% -$558K 0.03% 133
2015
Q4
$17.5M Hold
254,268
0.03% 122
2015
Q3
$15.1M Sell
254,268
-9,809
-4% -$622K 0.03% 130
2015
Q2
$17.6M Sell
264,077
-10,344
-4% -$682K 0.03% 119
2015
Q1
$17.7M Buy
274,421
+144,854
+112% +$9.07M 0.03% 122
2014
Q4
$7.65M Buy
129,567
+2,860
+2% +$161K 0.02% 158
2014
Q3
$6.49M Sell
126,707
-6,672
-5% -$333K 0.01% 163
2014
Q2
$6.47M Sell
133,379
-407,311
-75% -$20.1M 0.01% 168
2014
Q1
$28.1M Sell
540,690
-12,620
-2% -$672K 0.07% 112
2013
Q4
$29.4M Buy
553,310
+164,090
+42% +$8.36M 0.07% 108
2013
Q3
$18M Buy
389,220
+16,244
+4% +$713K 0.05% 121
2013
Q2
$16.7M Buy
+372,976
New +$16.2M 0.05% 117

Other funds holding BMY